The role of the purinergic P2X7 receptor in inflammation
2007

The Role of the P2X7 Receptor in Inflammation

publication Evidence: moderate

Author Information

Author(s): Martin F Lister, John Sharkey, Deborah A Sawatzky, Joseph P Hodgkiss, Donald J Davidson, Adriano G Rossi, Keith Finlayson

Primary Institution: MRC Centre for Inflammation Research, The Queen's Medical Research Institute, The University of Edinburgh

Hypothesis

The P2X7 receptor is an important regulator of inflammatory processes and may serve as a therapeutic target for chronic inflammatory diseases.

Conclusion

The P2X7 receptor plays a crucial role in the regulation of pro-inflammatory cytokines and may be a potential target for new anti-inflammatory therapies.

Supporting Evidence

  • The P2X7 receptor is involved in the production of key inflammatory cytokines like IL-1β and TNF-α.
  • Antagonists of the P2X7 receptor may have therapeutic potential in treating chronic inflammatory diseases.
  • Polymorphisms in the P2X7 receptor gene can affect individual susceptibility to inflammation and related diseases.

Takeaway

The P2X7 receptor helps control inflammation in the body, and understanding it could lead to new treatments for diseases like arthritis and cancer.

Methodology

This review summarizes recent advances in understanding the P2X7 receptor's role in inflammation and its potential as a therapeutic target.

Limitations

The review is based on existing literature and may not include all recent findings or perspectives.

Digital Object Identifier (DOI)

10.1186/1476-9255-4-5

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication